TickerFacts.

Labcorp Holdings Inc. (LH): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$532.30M
As of 2025-12-31
$141.80M
As of 2026-06-30
+18.4%
3-year compound annual growth
$1.52B2007-12-31: $56.40M2008-12-31: $219.70M2009-12-31: $148.50M2010-12-31: $230.70M2011-12-31: $159.30M2012-12-31: $466.80M2013-12-31: $404.00M2014-12-31: $580.00M2015-12-31: $716.40M2016-12-31: $433.60M2017-12-31: $316.60M2018-12-31: $426.80M2019-12-31: $337.50M2020-12-31: $1.32B2021-12-31: $1.47B2022-12-31: $320.60M2023-12-31: $536.80M2024-12-31: $1.52B2025-12-31: $532.30M$532.30M
2007-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$532.30M-65.0%2026-02-24, Balance as of period end
2024-12-31$1.52B+182.9%2026-02-24, Balance as of period end
2023-12-31$536.80M+67.4%2026-02-24, Balance as of period end
2022-12-31$320.60Mn/c2025-02-25, Balance as of period end
2021-12-31$1.47B+11.5%2023-02-28, Balance as of period end
2020-12-31$1.32B+291.3%2022-02-25, Balance as of period end
2019-12-31$337.50M-20.9%2021-02-25, Balance as of period end
2018-12-31$426.80M+34.8%2021-02-25, Balance as of period end
2017-12-31$316.60M-27.0%2020-02-28, Balance as of period end
2016-12-31$433.60M-39.5%2019-02-28, Balance as of period end
2015-12-31$716.40M+23.5%2018-02-27, Balance as of period end
2014-12-31$580.00M+43.6%2017-02-27, Balance as of period end
2013-12-31$404.00M-13.5%2016-03-01, Balance as of period end
2012-12-31$466.80M+193.0%2015-02-26, Balance as of period end
2011-12-31$159.30M-30.9%2014-02-25, Balance as of period end
2010-12-31$230.70M+55.4%2013-02-26, Balance as of period end
2009-12-31$148.50M-32.4%2012-02-24, Balance as of period end
2008-12-31$219.70M+289.5%2011-03-07, Balance as of period end
2007-12-31$56.40Mn/a2010-02-24, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Labcorp Holdings Inc. (LH)2025-12-31$532.30M-65.0%
Quest Diagnostics Inc (DGX)2025-12-31$420.00M-23.5%
Fortrea Holdings Inc. (FTRE)2025-12-31$174.60M+47.3%
RadNet, Inc. (RDNT)2025-12-31$767.22M+3.7%
Guardant Health, Inc. (GH)2025-12-31$378.20M-28.0%
Caris Life Sciences, Inc. (CAI)2025-12-31$796.27Mn/m
Veracyte, Inc. (VCYT)2025-12-31$362.58M+51.7%
CareDx, Inc. (CDNA)2025-12-31$65.43M-43.0%
Castle Biosciences Inc (CSTL)2025-12-31$116.73M-2.5%

Compare LH, DGX, FTRE, RDNT side by side · Screen every company in Services-Medical Laboratories ↗